Family Medicine · Idaho Falls, ID
NPI
1922086552
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2065 E 17th, Ste C
Idaho Falls, ID, 83404
Phone (208) 522-6106
Groups this clinician bills Medicare through
Medicare paid, 2024
$95K
1,833 services
Medicare patients, 2024
205
Average age 76
Drug cost, 2024
$1.3M
6,342 prescriptions
Company payments, 2025
$2,281
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julian de Bruyn Kops III was code 99214 (office e&m - established), 840 times for 192 patients. In total Julian de Bruyn Kops III billed 1,833 services in 11 codes, and Medicare paid $95K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 840 | 192 | $83.55 | $70K |
| 95165 Treatment - Miscellaneous | Office | 660 | 17 | $9.66 | $6,375 |
| 95117 Treatment - Miscellaneous | Office | 167 | 19 | $8.17 | $1,364 |
| 99215 Office E&M - Established | Office | 64 | 51 | $130.61 | $8,359 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 38 | 16 | $26.74 | $1,016 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 32 | 32 | $123.62 | $3,956 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 15 | 15 | $199.66 | $2,995 |
By year: 2022 $92K for 2,495 services; 2023 $93K for 2,146 services; 2024 $95K for 1,833 services.
Medicare prescription drug claims, 2024
In 2024, the drug Julian de Bruyn Kops III prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 480 prescriptions and refills. In total Julian de Bruyn Kops III wrote 6,342 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 480 | 535 | 61 | $545K |
| Levothyroxine Sodium Generic | 375 | 1,059 | 105 | $4,172 |
| Atorvastatin Calcium Generic | 300 | 808 | 78 | $2,097 |
| Ezetimibe Generic | 203 | 601 | 66 | $4,038 |
| Losartan Potassium Generic | 194 | 506 | 53 | $1,625 |
| Montelukast Sodium Generic | 180 | 509 | 54 | $1,546 |
| Metoprolol Succinate Generic | 172 | 450 | 44 | $2,791 |
| Metformin Hcl Er Metformin Hcl | 166 | 490 | 55 | $872 |
| Spironolactone Generic | 160 | 441 | 51 | $1,024 |
| Omeprazole Generic | 145 | 393 | 43 | $1,792 |
| Hydrochlorothiazide Generic | 132 | 340 | 40 | $748 |
| Amlodipine Besylate Generic | 128 | 378 | 38 | $682 |
| Furosemide Generic | 124 | 296 | 36 | $730 |
| Potassium Chloride Generic | 122 | 332 | 39 | $4,317 |
| Carvedilol Generic | 113 | 279 | 32 | $1,146 |
Brand drugs: 1,308 claims; generic drugs: 4,986 claims; opioid claims: 60.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julian de Bruyn Kops III $2,281 ($2,281 in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $365.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 21 | $365 |
| Novo Nordisk Inc NVO | 10 | $322 |
| Abbvie Inc. ABBV | 7 | $242 |
| Corcept Therapeutics CORT | 6 | $191 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $182 |
| Lilly USA, LLC LLY | 8 | $167 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $153 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $141 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $118 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.